Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials

Yang Liu; Guomin Zhao; Xuefeng Zang; Feiping Lu; Ping Liu; Wei Chen

doi:10.5114/wiitm.2021.104197

eISSN: 2299-0054
ISSN: 1895-4588

Videosurgery and Other Miniinvasive Techniques

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2021
vol. 16

Send email

Copy url:

Anaesthesiology

abstract:

Meta-analysis

Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis of randomized controlled trials

Yang Liu

¹

,

Guomin Zhao

¹

,

Xuefeng Zang

¹

,

Feiping Lu

¹

,

Ping Liu

¹

,

Wei Chen

¹

Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Videosurgery Miniinv 2021; 16 (3): 491–500

DOI: https://doi.org/10.5114/wiitm.2021.104197

Online publish date: 2021/03/08

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Liu Y, Zhao G, Zang X, Lu F, Liu P, Chen W. Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials. Videosurgery and Other Miniinvasive Techniques. 2021:491-500. doi:10.5114/wiitm.2021.104197.

APA

Liu, Y., Zhao, G., Zang, X., Lu, F., Liu, P.,  & Chen, W. (2021). Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials. Videosurgery and Other Miniinvasive Techniques, 491-500. https://doi.org/10.5114/wiitm.2021.104197

Chicago

Liu, Yang, Guomin Zhao, Xuefeng Zang, Feiping Lu, Ping Liu,  and Wei Chen. 2021. "Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials". Videosurgery and Other Miniinvasive Techniques: 491-500. doi:10.5114/wiitm.2021.104197.

Harvard

Liu, Y., Zhao, G., Zang, X., Lu, F., Liu, P.,  and Chen, W. (2021). Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials. Videosurgery and Other Miniinvasive Techniques, pp.491-500. https://doi.org/10.5114/wiitm.2021.104197

MLA

Liu, Yang et al. "Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials." Videosurgery and Other Miniinvasive Techniques, 2021, pp. 491-500. doi:10.5114/wiitm.2021.104197.

Vancouver

Liu Y, Zhao G, Zang X, Lu F, Liu P, Chen W. Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis 
of randomized controlled trials. Videosurgery and Other Miniinvasive Techniques. 2021:491-500. doi:10.5114/wiitm.2021.104197.

PlumX metrics:

Introduction
The clinical evidence on dexmedetomidine (DEX) for postoperative pain scores and opioid consumption remains unclear in laparoscopic cholecystectomy (LC). Aim: To evaluate whether DEX could reduce opioid consumption and pain control after LC.

Material and methods
A meta-analysis search of EMBASE, PubMed and Cochrane CENTRAL databases was performed and randomized controlled trials (RCTs) comparing DEX with control for adult patients undergoing LC were searched. The primary outcome was opioid consumption in the first 24 h after the operation. The secondary outcomes were the time of first request of analgesia, visual analogue scale (VAS) scores 24 h after the operation, the incidence of patients’ need for rescue analgesics, opioid-related adverse effects, DEX-related adverse effects and other complications.

Results
There were fourteen aspects of twelve trials and 967 patients included in the analysis. DEX use significantly reduced the opioid consumption in the first 24 h after the operation (weighted mean difference (WMD), –19.17; 95% confidence interval (CI), –30.29 to –8.04; p = 0.0007), lengthened the time of first request of analgesia (WMD = 38.90; 95% CI: 0.88–76.93; p = 0.04) and lowered post-operative nausea or vomiting (PONV) (odds ratio (OR) = 0.49; 95% CI: 0.27–0.89; p = 0.02).

Conclusions
Intravenous DEX infusion significantly improved the duration of the analgesic effect and reduced postoperative opioid consumption. Moreover, lower incidence of post-operative nausea or vomiting was found in the DEX group.

keywords:

Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis of randomized controlled trials

Yang Liu 1 , Guomin Zhao 1 , Xuefeng Zang 1 , Feiping Lu 1 , Ping Liu 1 , Wei Chen 1

dexmedetomidine; pain; opioid consumption; visual analogue scale; meta-analysis

Yang Liu

¹

,

Guomin Zhao

¹

,

Xuefeng Zang

¹

,

Feiping Lu

¹

,

Ping Liu

¹

,

Wei Chen

¹